Percentage of women accessing antenatal care (ANC) services who were tested for syphilis (any visit)
Short name:
Pregnant Women Tested for Syphilis in ANC
Data type:
Percent
Indicator Id:
3248
Topic:
Health service coverage
Rationale:
Syphilis testing and treatment sufficiently early in pregnancy can effectively prevent adverse pregnancy outcomes caused by maternal syphilis exposure, and is the core intervention in control of congenital syphilis. Syphilis testing is part of the recommended basic antenatal services package; thus, testing of antenatal care attendees for syphilis is also a marker of the quality of provision of essential antenatal care services.
Definition:
What it measures: Percentage of women accessing antenatal care (ANC) services who were tested for syphilis
Numerator: Number of women attending ANC services who were tested for syphilis
Denominator: Number of women attending ANC services
Method of measurement
All pregnant women should be tested ("screened") for syphilis at their first antenatal care visit. Countries unable to distinguish first visit from subsequent visits can still report data on this indicator, but should clearly comment on this difference when reporting the data. Either non-treponemal tests that measure reaginic antibody (e.g., VDRL or RPR) or treponemal tests that measure treponemal antibody (e.g., TPHA, TPPA, EIA or rapid treponemal tests) may be used for screening. For this indicator simply being tested by either type of test is sufficient.
M&E Framework:
Output
Method of estimation:
Data from routine programmatic studies and reporting systems are collected nationally and regionally. WHO compiles this data through its system of monitoring and reporting on global progress in countries' health sector responses toward universal access to HIV prevention, treatment, care and support. WHO, UNICEF, and UNAIDS provide joint support as a component of the Global HIV/AIDS Response Progress Report.